As of 2024-12-14, the Relative Valuation of Novocure Ltd (NVCR) is (56.24) USD. This relative valuation is based on P/E multiples. With the latest stock price at 30.06 USD, the upside of Novocure Ltd based on Relative Valuation is -287.1%.
The range of the Relative Valuation is (57.50) - (60.44) USD.
Note: valuation result may not be accurate due to the company's negative earnings.
| Range | Selected | |
| Trailing P/E multiples | 41.5x - 52.9x | 47.2x |
| Forward P/E multiples | 29.5x - 43.7x | 34.0x |
| Fair Price | (57.50) - (60.44) | (56.24) |
| Upside | -291.3% - -301.1% | -287.1% |
| Date | P/E |
| 2024-12-11 | -22.49 |
| 2024-12-10 | -21.47 |
| 2024-12-09 | -20.70 |
| 2024-12-06 | -20.20 |
| 2024-12-05 | -19.22 |
| 2024-12-04 | -21.11 |
| 2024-12-03 | -22.04 |
| 2024-12-02 | -21.56 |
| 2024-11-29 | -14.48 |
| 2024-11-27 | -14.22 |
| 2024-11-26 | -12.92 |
| 2024-11-25 | -13.57 |
| 2024-11-22 | -12.81 |
| 2024-11-21 | -12.35 |
| 2024-11-20 | -12.18 |
| 2024-11-19 | -11.90 |
| 2024-11-18 | -11.36 |
| 2024-11-15 | -11.64 |
| 2024-11-14 | -11.97 |
| 2024-11-13 | -12.92 |
| 2024-11-12 | -12.87 |
| 2024-11-11 | -13.14 |
| 2024-11-08 | -12.60 |
| 2024-11-07 | -12.75 |
| 2024-11-06 | -13.07 |
| 2024-11-05 | -12.01 |
| 2024-11-04 | -11.98 |
| 2024-11-01 | -11.69 |
| 2024-10-31 | -10.97 |
| 2024-10-30 | -12.27 |
| 2024-10-29 | -12.20 |
| 2024-10-28 | -12.01 |
| 2024-10-25 | -12.09 |
| 2024-10-24 | -11.83 |
| 2024-10-23 | -11.69 |
| 2024-10-22 | -11.67 |
| 2024-10-21 | -11.75 |
| 2024-10-18 | -12.43 |
| 2024-10-17 | -12.21 |
| 2024-10-16 | -12.91 |
| 2024-10-15 | -12.84 |
| 2024-10-14 | -11.60 |
| 2024-10-11 | -11.38 |
| 2024-10-10 | -10.74 |
| 2024-10-09 | -10.59 |
| 2024-10-08 | -10.59 |
| 2024-10-07 | -10.55 |
| 2024-10-04 | -10.63 |
| 2024-10-03 | -10.50 |
| 2024-10-02 | -11.20 |